Loading the section…
The price of Biomea Fusion, Inc. (BMEA) on October 9, 2026 is 1.42 USD, +3.65% on the day. Over 52 weeks the stock traded between 0.8720 USD and 2.24 USD; the price now sits 40% of the way up that range. Over the past year the price changed by −15.48%. Market capitalization is 102.67 million USD, rank 218 among 373 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: 3 November 2026 · Earnings calendar
Change over the period shown (line colour): −13.94 %
Biomea Fusion, Inc. trades on Nasdaq under the ticker BMEA. The company belongs to the Health care sector. The trading history on this page starts on 16 April 2021.
Over the past 52 weeks BMEA has traded between 0.8720 $ and 2.24 $. As of 9 October 2026 the price stood 40.15 % of the way from the 52-week low to the high.
Over one year BMEA shares fell 15.48 %; over six months they fell 24.06 %. Volatility over 90 days is 72.49 %. Dividends are not included: this is price change only, as of 9 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 5.5, above the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 1.38 | 1.45 | 1.38 | 1.42 | 1M |
| 8 October 2026 | 1.32 | 1.38 | 1.30 | 1.37 | 2M |
| 7 October 2026 | 1.27 | 1.34 | 1.25 | 1.32 | 835,400 |
| 6 October 2026 | 1.28 | 1.31 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:1599 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070, US
BMEA has a return on equity of −240.13 %, below the sector median of −41.68 %. Return on assets is −96.91 %, below the sector median of −32.11 %.
| 1.2B |
| PFEPfizer, Inc. | 28.28 | +1.65 % | 922M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 1.24 |
| 1.25 |
| 797,000 |
| 5 October 2026 | 1.27 | 1.31 | 1.22 | 1.30 | 1M |
| 2 October 2026 | 1.30 | 1.31 | 1.26 | 1.27 | 843,200 |
| 1 October 2026 | 1.32 | 1.36 | 1.30 | 1.30 | 1M |
| 30 September 2026 | 1.29 | 1.37 | 1.26 | 1.33 | 1M |
| 29 September 2026 | 1.28 | 1.30 | 1.25 | 1.26 | 2M |
| 28 September 2026 | 1.32 | 1.37 | 1.27 | 1.29 | 1M |
| 25 September 2026 | 1.49 | 1.49 | 1.30 | 1.32 | 3M |
| 24 September 2026 | 1.46 | 1.50 | 1.39 | 1.49 | 2M |
| 23 September 2026 | 1.70 | 1.72 | 1.35 | 1.44 | 9M |
| 22 September 2026 | 1.71 | 1.78 | 1.66 | 1.70 | 2M |
| 21 September 2026 | 1.84 | 1.85 | 1.68 | 1.71 | 2M |
| 18 September 2026 | 1.79 | 1.93 | 1.77 | 1.83 | 2M |
| 17 September 2026 | 1.78 | 1.84 | 1.72 | 1.79 | 1M |
| 16 September 2026 | 1.80 | 1.84 | 1.71 | 1.74 | 2M |
| 15 September 2026 | 1.79 | 1.82 | 1.66 | 1.80 | 1M |
| 14 September 2026 | 1.72 | 1.79 | 1.66 | 1.78 | 2M |